Chin P - Search Results

1

Fingolimod therapy in early multiple sclerosis: an efficacy analysis of the TRANSFORMS and FREEDOMS studies by time since first symptom.

Agius M, Meng X, Chin P, Grinspan A, Hashmonay R. Agius M, et al. Among authors: chin p. CNS Neurosci Ther. 2014 May;20(5):446-51. doi: 10.1111/cns.12235. Epub 2014 Mar 31. CNS Neurosci Ther. 2014. PMID: 24684973 Free PMC article. Clinical Trial.

2

Impact of a switch to fingolimod on depressive symptoms in patients with relapsing multiple sclerosis: An analysis from the EPOC (Evaluate Patient OutComes) trial.

Hunter SF, Agius M, Miller DM, Cutter G, Barbato L, McCague K, Meng X, Agashivala N, Chin P, Hollander E. Hunter SF, et al. Among authors: chin p. J Neurol Sci. 2016 Jun 15;365:190-8. doi: 10.1016/j.jns.2016.03.024. Epub 2016 Mar 22. J Neurol Sci. 2016. PMID: 27206905 Clinical Trial.

3

Effect of switching from intramuscular interferon β-1a to oral fingolimod on time to relapse in patients with relapsing-remitting multiple sclerosis enrolled in a 1-year extension of TRANSFORMS.

Meng X, Chin PS, Hashmonay R, Zahur Islam M, Cutter G. Meng X, et al. Contemp Clin Trials. 2015 Mar;41:69-74. doi: 10.1016/j.cct.2014.12.011. Epub 2014 Dec 26. Contemp Clin Trials. 2015. PMID: 25545026 Free article. Clinical Trial.

4

Onset of clinical and MRI efficacy occurs early after fingolimod treatment initiation in relapsing multiple sclerosis.

Kappos L, Radue EW, Chin P, Ritter S, Tomic D, Lublin F. Kappos L, et al. Among authors: chin p. J Neurol. 2016 Feb;263(2):354-360. doi: 10.1007/s00415-015-7978-y. Epub 2015 Dec 8. J Neurol. 2016. PMID: 26645392 Free PMC article. Clinical Trial.

5

Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.

Hauser SL, Bar-Or A, Comi G, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Montalban X, Rammohan KW, Selmaj K, Traboulsee A, Wolinsky JS, Arnold DL, Klingelschmitt G, Masterman D, Fontoura P, Belachew S, Chin P, Mairon N, Garren H, Kappos L; OPERA I and OPERA II Clinical Investigators. Hauser SL, et al. Among authors: chin p. N Engl J Med. 2017 Jan 19;376(3):221-234. doi: 10.1056/NEJMoa1601277. Epub 2016 Dec 21. N Engl J Med. 2017. PMID: 28002679 Free article. Clinical Trial.

6

Estimating time to disease progression comparing transition models and survival methods--an analysis of multiple sclerosis data.

Mandel M, Mercier F, Eckert B, Chin P, Betensky RA. Mandel M, et al. Among authors: chin p. Biometrics. 2013 Mar;69(1):225-34. doi: 10.1111/biom.12002. Epub 2013 Feb 14. Biometrics. 2013. PMID: 23410536 Free PMC article.

7

Fingolimod effect on brain volume loss independently contributes to its effect on disability.

Sormani MP, De Stefano N, Francis G, Sprenger T, Chin P, Radue EW, Kappos L. Sormani MP, et al. Among authors: chin p. Mult Scler. 2015 Jun;21(7):916-24. doi: 10.1177/1352458515569099. Epub 2015 Feb 6. Mult Scler. 2015. PMID: 25662353 Clinical Trial.

8

Evaluation of no evidence of progression or active disease (NEPAD) in patients with primary progressive multiple sclerosis in the ORATORIO trial.

Wolinsky JS, Montalban X, Hauser SL, Giovannoni G, Vermersch P, Bernasconi C, Deol-Bhullar G, Garren H, Chin P, Belachew S, Kappos L. Wolinsky JS, et al. Among authors: chin p. Ann Neurol. 2018 Oct;84(4):527-536. doi: 10.1002/ana.25313. Ann Neurol. 2018. PMID: 30155979 Free PMC article. Clinical Trial.

9

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis.

Montalban X, Hauser SL, Kappos L, Arnold DL, Bar-Or A, Comi G, de Seze J, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Rammohan KW, Selmaj K, Traboulsee A, Sauter A, Masterman D, Fontoura P, Belachew S, Garren H, Mairon N, Chin P, Wolinsky JS; ORATORIO Clinical Investigators. Montalban X, et al. Among authors: chin p. N Engl J Med. 2017 Jan 19;376(3):209-220. doi: 10.1056/NEJMoa1606468. Epub 2016 Dec 21. N Engl J Med. 2017. PMID: 28002688 Free article. Clinical Trial.

10

Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial.

Hawker K, O'Connor P, Freedman MS, Calabresi PA, Antel J, Simon J, Hauser S, Waubant E, Vollmer T, Panitch H, Zhang J, Chin P, Smith CH; OLYMPUS trial group. Hawker K, et al. Among authors: chin p. Ann Neurol. 2009 Oct;66(4):460-71. doi: 10.1002/ana.21867. Ann Neurol. 2009. PMID: 19847908 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

455 results

Search Page

Filters